Journal of the American Academy of Dermatology
Volume 61, Issue 6 , Pages 971-976, December 2009

A double-blind, randomized, placebo-controlled, dose-finding study of oral pramiconazole in the treatment of pityriasis versicolor

  • Jan Faergemann, MD, PhD

      Affiliations

    • Department of Dermatology, Sahlgrenska University Hospital, Göteborg, Sweden
    • Corresponding Author InformationReprint requests: Jan Faergemann, MD, PhD, Barrier Therapeutics, Cipalstraat 3, B-2440 Geel, Belgium.
    • ,
  • Gail Todd, MBChB

      Affiliations

    • Groote Schuur Hospital, Observatory, Cape Town, South Africa
    • ,
  • Sandrakantha Pather, MBChB

      Affiliations

    • Skin Centre, University Cape Town, Lung Institute, Cape Town, South Africa
    • ,
  • Zubar F.A. Vawda, MBChB

      Affiliations

    • private practice, Durban, South Africa
    • ,
  • John D. Gillies, MBChB

      Affiliations

    • P3 Research Ltd, Tauranga, New Zealand
    • ,
  • Ted Walford, MBChB

      Affiliations

    • P3 Research Ltd, Tauranga, New Zealand
    • ,
  • Charles Barranco, BA

      Affiliations

    • Barrier Therapeutics Inc, Princeton, New Jersey
    • ,
  • John N. Quiring, PhD

      Affiliations

    • QST Consultations Ltd, Allendale, Michigan
    • ,
  • Manuel Briones, MD

      Affiliations

    • Francisco Bolonã, Guayaquil, Ecuador

Accepted 18 August 2008. published online 14 October 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by Barrier Therapeutics, Inc.

 Conflicts of interest: None declared.

PII: S0190-9622(08)01075-X

doi:10.1016/j.jaad.2008.08.033

Journal of the American Academy of Dermatology
Volume 61, Issue 6 , Pages 971-976, December 2009

Article Tools

* Image Usage & Resolution